Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
- PMID: 28190076
- PMCID: PMC5407679
- DOI: 10.3791/54849
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Abstract
Currently, it is possible to construct recombinant forms of various viruses, such as human immunodeficiency virus 1 (HIV-1) and hepatitis C virus (HCV), that carry foreign genes such as a reporter or marker protein in their genomes. These recombinant viruses usually faithfully mimic the life cycle of the original virus in infected cells and exhibit the same host range dependence. The development of a recombinant virus enables the efficient screening of inhibitors and the identification of specific host factors. However, to date the construction of recombinant hepatitis B virus (HBV) has been difficult because of various experimental limitations. The main limitation is the compact genome size of HBV, and a fairly strict genome size that does not exceed 1.3 genome sizes, that must be packaged into virions. Thus, the size of a foreign gene to be inserted should be smaller than 0.4 kb if no deletion of the genome DNA is to be performed. Therefore, to overcome this size limitation, the deletion of some HBV DNA is required. Here, we report the construction of recombinant HBV encoding a reporter gene to monitor the early stage of the HBV replication cycle by replacing part of the HBV core-coding region with the reporter gene by deleting part of the HBV pol coding region. Detection of recombinant HBV infection, monitored by the reporter activity, was highly sensitive and less expensive than detection using the currently available conventional methods to evaluate HBV infection. This system will be useful for a number of applications including high-throughput screening for the identification of anti-HBV inhibitors, host factors and virus-susceptible cells.
Similar articles
-
Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.J Virol. 2001 Feb;75(3):1104-16. doi: 10.1128/JVI.75.3.1104-1116.2001. J Virol. 2001. PMID: 11152483 Free PMC article.
-
Investigating the hepatitis B virus life cycle using engineered reporter hepatitis B viruses.Cancer Sci. 2018 Jan;109(1):241-249. doi: 10.1111/cas.13440. Epub 2017 Dec 7. Cancer Sci. 2018. PMID: 29121422 Free PMC article.
-
Replication-competent infectious hepatitis B virus vectors carrying substantially sized transgenes by redesigned viral polymerase translation.PLoS One. 2013 Apr 2;8(4):e60306. doi: 10.1371/journal.pone.0060306. Print 2013. PLoS One. 2013. PMID: 23589756 Free PMC article.
-
A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation-and Beyond?Viruses. 2017 May 22;9(5):125. doi: 10.3390/v9050125. Viruses. 2017. PMID: 28531167 Free PMC article. Review.
-
Hepatitis B Virus X and Regulation of Viral Gene Expression.Cold Spring Harb Perspect Med. 2016 Jan 8;6(3):a021402. doi: 10.1101/cshperspect.a021402. Cold Spring Harb Perspect Med. 2016. PMID: 26747833 Free PMC article. Review.
Cited by
-
Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251.Biochem Biophys Rep. 2018 Jun 1;15:1-6. doi: 10.1016/j.bbrep.2018.05.007. eCollection 2018 Sep. Biochem Biophys Rep. 2018. PMID: 30023438 Free PMC article.
References
-
- Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127(5):35–50. Supple 1. - PubMed
-
- Revill P, Testoni B, Locarnini S, Zoulim F. Global strategies are required to cure and eliminate HBV infection. Nat. Rev. Gastroenterol. Hepatol. 2016;13(4):239–248. - PubMed
-
- Wursthorn K, et al. Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology. 2006;44(3):675–684. - PubMed
-
- Stuyver LJ, et al. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology. 2001;33(3):751–757. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources